These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 17275008)
1. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008 [TBL] [Abstract][Full Text] [Related]
2. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092 [TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026 [TBL] [Abstract][Full Text] [Related]
5. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. McComsey GA; O'Riordan M; Hazen SL; El-Bejjani D; Bhatt S; Brennan ML; Storer N; Adell J; Nakamoto DA; Dogra V AIDS; 2007 May; 21(8):921-7. PubMed ID: 17457085 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors of vascular intima media thickness in HIV-positive subjects. Bongiovanni M; Casana M; Cicconi P; Pisacreta M; Codemo R; Pelucchi M; d'Arminio Monforte A; Bini T J Antimicrob Chemother; 2008 Jan; 61(1):195-9. PubMed ID: 17999980 [TBL] [Abstract][Full Text] [Related]
7. Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Iacobellis G; Pellicelli AM; Sharma AM; Grisorio B; Barbarini G; Barbaro G Am J Cardiol; 2007 May; 99(10):1470-2. PubMed ID: 17493483 [TBL] [Abstract][Full Text] [Related]
8. Carotid intima-media thickness in HIV patients treated with antiretroviral therapy. Lebech AM; Wiinberg N; Kristoffersen US; Hesse B; Petersen CL; Gerstoft J; Kjaer A Clin Physiol Funct Imaging; 2007 May; 27(3):173-9. PubMed ID: 17445068 [TBL] [Abstract][Full Text] [Related]
9. Arterial stiffness and carotid intima-media thickness in HIV infected patients. Papita A; Albu A; Fodor D; Itu C; Cârstina D Med Ultrason; 2011 Jun; 13(2):127-34. PubMed ID: 21655539 [TBL] [Abstract][Full Text] [Related]
10. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Hanna DB; Guo M; Bůžková P; Miller TL; Post WS; Stein JH; Currier JS; Kronmal RA; Freiberg MS; Bennett SN; Shikuma CM; Anastos K; Li Y; Tracy RP; Hodis HN; Delaney JA; Kaplan RC Clin Infect Dis; 2016 Jul; 63(2):249-56. PubMed ID: 27118787 [TBL] [Abstract][Full Text] [Related]
11. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy. Jeong SJ; Kim CO; Song YG; Baek JH; Kim SB; Jin SJ; Ku NS; Han SH; Choi JY; Lee HC; Kim JM Atherosclerosis; 2011 Dec; 219(2):778-83. PubMed ID: 21872861 [TBL] [Abstract][Full Text] [Related]
12. Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study). de Saint Martin L; Vandhuick O; Guillo P; Bellein V; Bressollette L; Roudaut N; Amaral A; Pasquier E Atherosclerosis; 2006 Apr; 185(2):361-7. PubMed ID: 16137695 [TBL] [Abstract][Full Text] [Related]
13. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Gerli R; Sherer Y; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():281-90. PubMed ID: 16126969 [TBL] [Abstract][Full Text] [Related]
14. Sonographically measured perirenal fat thickness: an early predictor of atherosclerosis in HIV-1-infected patients receiving highly active antiretroviral therapy? Grima P; Guido M; Zizza A; Chiavaroli R J Clin Ultrasound; 2010 May; 38(4):190-5. PubMed ID: 20091697 [TBL] [Abstract][Full Text] [Related]
15. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. Currier JS; Kendall MA; Zackin R; Henry WK; Alston-Smith B; Torriani FJ; Schouten J; Mickelberg K; Li Y; Hodis HN; AIDS; 2005 Jun; 19(9):927-33. PubMed ID: 15905673 [TBL] [Abstract][Full Text] [Related]
16. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Stompór T; Kraśniak A; Sułowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tabor B; Kowalczyk-Michałek ME; Zdzienicka A; Janusz-Grzybowska E Nephrol Dial Transplant; 2005 Feb; 20(2):404-12. PubMed ID: 15618238 [TBL] [Abstract][Full Text] [Related]
17. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection. Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM; PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323 [TBL] [Abstract][Full Text] [Related]
18. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients]. Ferraro S; Paolillo S; Gargiulo M; Costanzo P; Maggi P; Chirianni A; Chiariello M; Filardi PP G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251 [TBL] [Abstract][Full Text] [Related]
19. Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. Vasunta RL; Kesäniemi YA; Ylitalo A; Ukkola O Am J Hypertens; 2012 Jan; 25(1):60-6. PubMed ID: 21866184 [TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients. Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]